These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 21540481

  • 41. Monitoring of concordance in growth hormone therapy.
    Kapoor RR, Burke SA, Sparrow SE, Hughes IA, Dunger DB, Ong KK, Acerini CL.
    Arch Dis Child; 2008 Feb; 93(2):147-8. PubMed ID: 17768149
    [Abstract] [Full Text] [Related]

  • 42. Growth hormone receptor exon 3 isoforms and their implication in growth disorders and treatment.
    Jorge AA, Arnhold IJ.
    Horm Res; 2009 Apr; 71 Suppl 2():55-63. PubMed ID: 19407498
    [Abstract] [Full Text] [Related]

  • 43. Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term.
    de Zegher F, Hokken-Koelega A.
    Pediatrics; 2005 Apr; 115(4):e458-62. PubMed ID: 15805349
    [Abstract] [Full Text] [Related]

  • 44. Growth hormone treatment of non-growth hormone-deficient growth disorders.
    Quigley CA.
    Endocrinol Metab Clin North Am; 2007 Mar; 36(1):131-86. PubMed ID: 17336739
    [Abstract] [Full Text] [Related]

  • 45. Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome.
    Höybye C, Thorén M, Böhm B.
    J Intellect Disabil Res; 2005 Apr; 49(Pt 4):245-52. PubMed ID: 15816811
    [Abstract] [Full Text] [Related]

  • 46. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
    Festen DA, de Lind van Wijngaarden R, van Eekelen M, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
    [Abstract] [Full Text] [Related]

  • 47. Effect of growth hormone therapy on severe short stature and skeletal deformities in a patient with combined Turner syndrome and Langer mesomelic dysplasia.
    Shah BC, Moran ES, Zinn AR, Pappas JG.
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5028-33. PubMed ID: 19850687
    [Abstract] [Full Text] [Related]

  • 48. [Growth Hormone treatment in children with Growth Hormone deficiency, idiopathic short stature, SHOX gene mutation, small for gestational age and Turner syndrome].
    Griffero González M, González Navarrete D, Tolosa Navarro F, López Cuevas P, Rodríguez Convertino F, Román Reyes R.
    Andes Pediatr; 2024 Apr; 95(2):151-158. PubMed ID: 38801362
    [Abstract] [Full Text] [Related]

  • 49. Diagnosis and treatment of GH deficiency in Prader-Willi syndrome.
    Grugni G, Marzullo P.
    Best Pract Res Clin Endocrinol Metab; 2016 Dec; 30(6):785-794. PubMed ID: 27974191
    [Abstract] [Full Text] [Related]

  • 50. Prader-Willi syndrome: who can have growth hormone?
    Stafler P, Wallis C.
    Arch Dis Child; 2008 Apr; 93(4):341-5. PubMed ID: 18089632
    [Abstract] [Full Text] [Related]

  • 51. Effectiveness and Overall Safety of NutropinAq® for Growth Hormone Deficiency and Other Paediatric Growth Hormone Disorders: Completion of the International Cooperative Growth Study, NutropinAq® European Registry (iNCGS).
    Coutant R, Bosch Muñoz J, Dumitrescu CP, Schnabel D, Sert C, Perrot V, Dattani M.
    Front Endocrinol (Lausanne); 2021 Apr; 12():676083. PubMed ID: 34113318
    [Abstract] [Full Text] [Related]

  • 52. Growth hormone-induced increases in skeletal muscle mass alleviates the associated insulin resistance in short children born small for gestational age, but not with growth hormone deficiency.
    Martin DD, Schweizer R, Schönau E, Binder G, Ranke MB.
    Horm Res; 2009 Apr; 72(1):38-45. PubMed ID: 19571558
    [Abstract] [Full Text] [Related]

  • 53. Growth hormone therapy-established uses in short children.
    Schwenk WF.
    Acta Paediatr Suppl; 2006 Jul; 95(452):6-8. PubMed ID: 16801157
    [Abstract] [Full Text] [Related]

  • 54. Growth hormone induced lipolysis during short- and long-term administration in adult Prader-Willi patients.
    Höybye C, Hilding A, Marcus C, Thorén M.
    Growth Horm IGF Res; 2005 Dec; 15(6):411-5. PubMed ID: 16230042
    [Abstract] [Full Text] [Related]

  • 55. Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age.
    Feinberg MS, Scheinowitz M, Laron Z.
    Am Heart J; 2003 Mar; 145(3):549-53. PubMed ID: 12660681
    [Abstract] [Full Text] [Related]

  • 56. Growth hormone treatment in Japan: past, present, and future.
    Tanaka T.
    Pediatr Endocrinol Rev; 2012 Oct; 10 Suppl 1():89-97. PubMed ID: 23330250
    [Abstract] [Full Text] [Related]

  • 57. Effect of long-term recombinant growth hormone therapy in children--the National Cooperative Growth Study, USA, 1985-1994.
    Root AW, Kemp SF, Rundle AC, Dana K, Attie KM.
    J Pediatr Endocrinol Metab; 1998 Oct; 11(3):403-12. PubMed ID: 11517956
    [Abstract] [Full Text] [Related]

  • 58. Real-life GH dosing patterns in children with GHD, TS or born SGA: a report from the NordiNet® International Outcome Study.
    Blankenstein O, Snajderova M, Blair J, Pournara E, Pedersen BT, Petit IO.
    Eur J Endocrinol; 2017 Aug; 177(2):145-155. PubMed ID: 28522645
    [Abstract] [Full Text] [Related]

  • 59. The DATAC study: a new growth database. Description of the epidemiology, diagnosis and therapeutic attitude in a group of Spanish children with short stature.
    Rodríguez Arnao MD, Sánchez AR, García-Rey C, Arroyo Díez FJ, Estrada RC, Cuartero BG, Merillas MA, López-Siguero JP, DATAC study group.
    J Pediatr Endocrinol Metab; 2014 Nov; 27(11-12):1201-8. PubMed ID: 25210749
    [Abstract] [Full Text] [Related]

  • 60. A review of guidelines for use of growth hormone in pediatric and transition patients.
    Cook DM, Rose SR.
    Pituitary; 2012 Sep; 15(3):301-10. PubMed ID: 22271255
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.